Osborne Clarke advised Fortino Capital on the deal. Fortino Capital invested in Addactis to accelerate the growth of this specialist in actuarial B2B SaaS software. Addactis succesfully...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised OncoDNA on the fundraising. OncoDNA announced its Round C financing of €6.5 million. Both private (including Vesalius BioCapital III, Ackermans & van Haaren,...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Sunrise. Sunrise recently raised €17 million to support the roll out of their ground-breaking sleep research in Europe and the American market. Sunrise’s...
You must be a Standard 1 Year member to access this content.
